Evaluation of Medication Patient care model in Dibigatran Patients at Roi Et Hospital

Abstract

Purposes: To study the effects of a new care model for patients receiving dabigatran by comparing medication knowledge, drug-related problems (DRPs), and adverse drug reactions between the control group and the intervention group.

Study design: Quasi-experimental research.

Materials and Methods: The sample consisted of 60 outpatients receiving dabigatran at Roi Et Hospital, divided into a control group (n=30) and an intervention group (n=30). The study was conducted from March 1, 2025, to August 31, 2025. The new care model incorporated a dabigatran medication assessment form and a patient medication passport into the care process. Data analysis employed the Mann-Whitney U test and Chi-square test.

Main findings: The intervention group demonstrated significantly higher mean knowledge scores regarding dabigatran compared to the control group (p < .001). Regarding drug-related problems (DRPs), the intervention group experienced significantly fewer problems than the control group (p< .001). The primary issue in the control group was patient non-adherence (50%). For adverse drug reactions, the intervention group had significantly fewer occurrences than the control group (p = .005). The control group experienced adverse reactions in 26.7% of cases (8 patients), while the intervention group had no adverse reactions (100.0% adverse reaction-free). Regarding medication appropriateness, 100.0% of the intervention group received appropriate dosages, compared to 93.3% in the control group.

Conclusion and Recommendations: The implementation of the medication assessment form and patient passport in the new care model effectively increased patient knowledge and understanding, and significantly reduced drug-related problems and adverse reactions. It is recommended that this developed care model be expanded to other healthcare service units to enhance medication safety, and electronic media should be developed.